
You can purchase shares of VanEck Biotech ETF (NASDAQ:BBH) through any online brokerage.
There are no as such competitors for VanEck Biotech ETF.
There is no analysis for VanEck Biotech ETF to provide a consensus price target.
The stock price for VanEck Biotech ETF (NASDAQ: BBH) is $244.95 last updated October 2, 2026 at 8:34 AM EDT.
There are no upcoming dividends for VanEck Biotech ETF.
VanEck Biotech ETF does not have any upcoming earnings scheduled.
There is no upcoming split for VanEck Biotech ETF.
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Growth |
| Fund Inception | Dec 20, 2011 |
| Managers | Peter H. Liao Griffin Driscoll |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
| Symbol | Name | Share % |
|---|---|---|
| AMGN | Amgen Inc. | 14.1% |
| VRTX | Vertex Pharmaceuticals... | 8.37% |
| REGN | Regeneron Pharmaceutic... | 6.90% |
| GILD | Gilead Sciences Inc | 12.9% |
| AS | Argenx Se Sponsored Ad... | 4.68% |
| IQV | Iqvia Holdings Inc. | 5.17% |
| NTRA | Natera Inc | 5.28% |
| RVMD | Revolution Medicines I... | 5.09% |
| ILMN | Illumina, Inc. | 3.30% |
| MRNA | Moderna Inc | 6.13% |
Benzinga Rankings give you vital metrics on any stock – anytime.